NREP
NEW REPRESENTATIVE AT IB RECEIVED
15/08/2025
Voltar para busca
Dado oficial do USPTO
IMMULAB
Sabia que essa marca já está registrada no Estados Unidos?
Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.
Active USPTO registrationTipo: MistaEscritório: US
Diagnóstico de risco e oportunidade
Leitura executiva para decisão de naming, protocolo e monitoramento.
Situação USPTO
Active USPTO registration
Tipo de processo
Pedido e registro
Eventos registrados
23
Atualização mais recente
16/08/2025
Classificação
Registrada
Tipo de marca
Mista
Classes Nice
1, 5
Data de depósito
04/10/2021
Data de registro
10/01/2023
Data de expiração
-
Ação recomendada
Execute uma análise de colidência completa e valide classes antes de qualquer protocolo ou investimento de marca.
Próximo passo
Esses são os detalhes do processo de registro. Mesmo assim, o monitoramento constante é o que garante tranquilidade de que o seu principal ativo continue protegido.
Dados completos do processo
Campos estruturados da autoridade responsável e do histórico oficial.
Data da situação
10/01/2023
Última transação
16/08/2025
Escritório responsável
United States Patent and Trademark Office
Código da situação
700
Cadastro oficial
Principal Register
Código do desenho
3
Tipo de titular
99
Localização do titular
AU
Examinador
SINGH, TEJBIR
Unidade examinadora
L60
Localização atual
PUBLICATION AND ISSUE SECTION
Descrição da marca
The mark consists of of the wording IMMULAB, with two dots over the letter I in blue, with LAB in blue, and with IMMU in gray. To the right is a black, gray, and blue butterfly.
Titulares e representantes
Titulares
Immulab Pty Ltd
Representantes
Rebecca Liebowitz Venable LLP
Classificação técnica
Classes Nice
Classe 1Classe 5
Códigos Vienna
Sem códigos Vienna disponíveis.
Produtos e serviços
Classe 1
Chemical and biological reagents for non-medical purposes; chemical test kits comprised of chemical preparations for the detection of specific blood cellsdetermining the presence of antigens on blood cellsthe detection of relevant complement compounds and immunoglobulin subtypes for laboratory or research use; chemical preparations for scientific and/or industrial purposes; diagnostic and chemical reagents for testing for scientific and research purposes; chemical and biological reagents for non-medical purposes; chemical and biological reagents for anti-body screeningblood groupingfor the typing and detection of specific blood cellsdetermining the presence of antigens on blood cellsthe detection of relevant complement compounds and immunoglobulin subtypesall the aforesaid being for scientific and research purposes; chemical test kits for the detection of specific blood cellsdetermining the presence of antigens on blood cellsthe detection of relevant complement compounds and immunoglobulin subtypes for laboratory or research use; chemical preparations for anti-body screeningblood groupingthe typing and detection of specific blood cells for scientific and research purposes
Classe 5
Pharmaceutical preparations and substancesblood grouping serums and blood typing serumsmedical reagents and assays for testing blood to determine blood type; blood components for medical purposesplateletsplasma and red blood cells; pharmaceutical test kits in this classbeing for diagnostic medical purposesdiagnostic test kits comprised of medical diagnostic reagents and assays for clinical laboratory use in use in blood grouping and antibody screening; blood products for medical purposesblood plasmareagent blood cells; reagents for medical usereagents for the typing and detection of specific blood cellsthe detection of relevant compliment components and immunoglobulin subtypes; clinical medical reagents for the typing and detection of specific blood cellsthe detection of relevant compliment components and immunoglobulin subtypes; pharmaceutical preparationsreagent red blood cells used for quality control in immunohematology tests to detect antibodies or immunoglobulin subtypes; diagnostic reagents for medical or veterinary use; pharmaceutical preparationsreagent red blood cells for medical use and medical testing used to detect antibodies or immunoglobulin subtypes; test kits comprised of medical diagnostic reagents and assays for testing of body fluids; chemical reagents for medical purposes; biological reagents for medical use
Publicações
Histórico de despachos e eventos da marca no USPTO.
23 publicações encontradas
FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
17/05/2023
FICS
FINAL DISPOSITION NOTICE SENT TO IB
26/04/2023
FIMP
FINAL DISPOSITION PROCESSED
26/04/2023
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
10/04/2023
NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
10/01/2023
R.PR
REGISTERED-PRINCIPAL REGISTER
10/01/2023
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
25/10/2022
PUBO
PUBLISHED FOR OPPOSITION
25/10/2022
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
05/10/2022
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
19/09/2022
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
26/08/2022
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
25/08/2022
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
25/08/2022
RFNT
REFUSAL PROCESSED BY IB
23/08/2022
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
29/07/2022
RFRR
REFUSAL PROCESSED BY MPU
29/07/2022
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
08/07/2022
CNRT
NON-FINAL ACTION WRITTEN
07/07/2022
DOCK
ASSIGNED TO EXAMINER
07/07/2022
MAFR
APPLICATION FILING RECEIPT MAILED
29/03/2022
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
25/03/2022
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
24/03/2022
Proteção contínua da sua marca
Seja avisado a cada novo depósito que ameace IMMULAB ou a sua marca.
Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.